Latest Breaking News On - Rhythm pharmaceutical - Page 1 : comparemela.com

Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Update - Rhythm Pharmaceuticals (NASDAQ:RYTM)

Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Update - Rhythm Pharmaceuticals (NASDAQ:RYTM)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomDavid connollyAdam daleyDavid meekerExchange commissionDiscovery fundBerry company public relationsUnited kingdom medicines healthcare products regulatory agencyDrug administrationRhythm pharmaceuticals incCorporate communicationsRhythm pharmaceuticalsCompany phasePediatric endocrine societyPerceptive advisors

Rhythm Pharmaceuticals, Inc (NASDAQ:RYTM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Shareholders might have noticed that Rhythm Pharmaceuticals, Inc. ( NASDAQ:RYTM ) filed its yearly result this time.

Rhythm pharmaceuticalsRhythm pharmaceuticalRevenue estimatesPrice target

Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update

Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomDavid connollyAdam daleyDavid meekerUnited kingdom medicines healthcare products regulatory agencyJapan pharmaceuticalsItalian medicine agencyRhythm pharmaceuticals incLg chem ltdExchange commissionDevices agencyDrug administrationCorporate communicationsEuropean unionEuropean commission

PRIMECAP Management Reduces Stake in Rhythm Pharmaceuticals

PRIMECAP Management (Trades, Portfolio), a notable investment firm, has recently adjusted its investment portfolio by reducing its stake in Rhythm Pharmaceuticals Inc (NASDAQ:RYTM). This move, executed on December 31, 2023, reflects the firm's ongoing portfolio management strategy and its assessment of RYTM's investment potential.

United statesFinancial health of rhythm pharmaceuticalsRhythm pharmaceuticals incRhythm pharmaceuticalsAbout rhythm pharmaceuticalsPharmaceuticals incPharmaceutical stock performanceFinancial strengthBalance sheet rankProfitability rankGrowth rankPiotroskif scoreJoel greenblattRhythm pharmaceuticalPrimecap managementInvestment portfolio

Analyzing Enveric Biosciences (NASDAQ:ENVB) and Rhythm Pharmaceuticals (NASDAQ:RYTM)

Analyzing Enveric Biosciences (NASDAQ:ENVB) and Rhythm Pharmaceuticals (NASDAQ:RYTM)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesEnveric biosciencesRhythm pharmaceuticals incRhythm pharmaceuticalsRhythm metabolic incEnveric biosciences incGet free reportRhythm pharmaceuticalGiven rhythm pharmaceuticalRhythm metabolicEnveric biosciences daily